BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 15902689)

  • 1. New tools to identify regulatory T cells.
    Graca L
    Eur J Immunol; 2005 Jun; 35(6):1678-80. PubMed ID: 15902689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A function for interleukin 2 in Foxp3-expressing regulatory T cells.
    Fontenot JD; Rasmussen JP; Gavin MA; Rudensky AY
    Nat Immunol; 2005 Nov; 6(11):1142-51. PubMed ID: 16227984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M; Piccirillo CA
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3.
    Williams LM; Rudensky AY
    Nat Immunol; 2007 Mar; 8(3):277-84. PubMed ID: 17220892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling.
    D'Cruz LM; Klein L
    Nat Immunol; 2005 Nov; 6(11):1152-9. PubMed ID: 16227983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3.
    Fontenot JD; Rudensky AY
    Nat Immunol; 2005 Apr; 6(4):331-7. PubMed ID: 15785758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10.
    Maynard CL; Harrington LE; Janowski KM; Oliver JR; Zindl CL; Rudensky AY; Weaver CT
    Nat Immunol; 2007 Sep; 8(9):931-41. PubMed ID: 17694059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-tumoural regulatory T cells: a potential new target in cancer immunotherapy.
    Needham DJ; Lee JX; Beilharz MW
    Biochem Biophys Res Commun; 2006 May; 343(3):684-91. PubMed ID: 16563349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited role of CD4+Foxp3+ regulatory T cells in the control of experimental cerebral malaria.
    Steeg C; Adler G; Sparwasser T; Fleischer B; Jacobs T
    J Immunol; 2009 Dec; 183(11):7014-22. PubMed ID: 19890049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires.
    Hsieh CS; Zheng Y; Liang Y; Fontenot JD; Rudensky AY
    Nat Immunol; 2006 Apr; 7(4):401-10. PubMed ID: 16532000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of Foxp3 function and expression in the thymic epithelium.
    Liston A; Farr AG; Chen Z; Benoist C; Mathis D; Manley NR; Rudensky AY
    J Exp Med; 2007 Mar; 204(3):475-80. PubMed ID: 17353370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes.
    Tritt M; Sgouroudis E; d'Hennezel E; Albanese A; Piccirillo CA
    Diabetes; 2008 Jan; 57(1):113-23. PubMed ID: 17928397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deacetylase inhibition promotes the generation and function of regulatory T cells.
    Tao R; de Zoeten EF; Ozkaynak E; Chen C; Wang L; Porrett PM; Li B; Turka LA; Olson EN; Greene MI; Wells AD; Hancock WW
    Nat Med; 2007 Nov; 13(11):1299-307. PubMed ID: 17922010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice.
    Kim JM; Rasmussen JP; Rudensky AY
    Nat Immunol; 2007 Feb; 8(2):191-7. PubMed ID: 17136045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro-generated regulatory T cells induced by Foxp3-retrovirus infection control murine contact allergy and systemic autoimmunity.
    Loser K; Hansen W; Apelt J; Balkow S; Buer J; Beissert S
    Gene Ther; 2005 Sep; 12(17):1294-304. PubMed ID: 15973443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The levels of CD4+CD25+ regulatory T cells in paediatric patients with allergic rhinitis and bronchial asthma.
    Lee JH; Yu HH; Wang LC; Yang YH; Lin YT; Chiang BL
    Clin Exp Immunol; 2007 Apr; 148(1):53-63. PubMed ID: 17349011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+CD25+FoxP3+ regulatory T cells in autoimmune diseases.
    Valencia X; Lipsky PE
    Nat Clin Pract Rheumatol; 2007 Nov; 3(11):619-26. PubMed ID: 17968332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential changes in CD4+ and CD8+ effector and regulatory T lymphocyte subsets in the testis of rats undergoing autoimmune orchitis.
    Jacobo P; Guazzone VA; Jarazo-Dietrich S; Theas MS; Lustig L
    J Reprod Immunol; 2009 Jul; 81(1):44-54. PubMed ID: 19520436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling IL-2 gene expression in human regulatory T cells.
    Benary M; Bendfeldt H; Baumgrass R; Herzel H
    Genome Inform; 2008; 20():222-30. PubMed ID: 19425136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sublingual tolerance induction with antigen conjugated to cholera toxin B subunit induces Foxp3+CD25+CD4+ regulatory T cells and suppresses delayed-type hypersensitivity reactions.
    Sun JB; Cuburu N; Blomquist M; Li BL; Czerkinsky C; Holmgren J
    Scand J Immunol; 2006 Sep; 64(3):251-9. PubMed ID: 16918694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.